JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB263206

Human FUK knockout HEK-293T cell lysate

Be the first to review this product! Submit a review

|

(0 Publication)

FCSK KO cell lysate available now. KO validated by. Free of charge wild type control included. Knockout achieved by using CRISPR/Cas9, 10 bp deletion in exon 11 and 1 bp deletion in exon 11 and 25 bp deletion in exon 11.

View Alternative Names

1110046B12Rik, FLJ39408, FUK_HUMAN, Fucokinase, L-fucose kinase

3 Images
Sanger Sequencing - Human FUK knockout HEK-293T cell lysate (AB263206)
  • Sanger seq

Unknown

Sanger Sequencing - Human FUK knockout HEK-293T cell lysate (AB263206)

Allele-3 : 1 bp deletion in exon11

Sanger Sequencing - Human FUK knockout HEK-293T cell lysate (AB263206)
  • Sanger seq

Unknown

Sanger Sequencing - Human FUK knockout HEK-293T cell lysate (AB263206)

Allele-1 : 25 bp deletion in exon11

Sanger Sequencing - Human FUK knockout HEK-293T cell lysate (AB263206)
  • Sanger seq

Unknown

Sanger Sequencing - Human FUK knockout HEK-293T cell lysate (AB263206)

Allele-2 : 10 bp deletion in exon11

Key facts

Cell type

HEK-293T

Species or organism

Human

Tissue

Kidney

Knockout validation

Sanger Sequencing

Mutation description

Knockout achieved by using CRISPR/Cas9, 10 bp deletion in exon 11 and 1 bp deletion in exon 11 and 25 bp deletion in exon 11

Product details

Knockout cell lysate achieved by CRISPR/Cas9.

REACH authorisation
Abcam has not and does not intend to apply for the REACH Authorisation of customers' uses of products that contain European Authorisation list (Annex XIV) substances.
It is the responsibility of our customers to check the necessity of application of REACH Authorisation, and any other relevant authorisations, for their intended uses.

Lysate preparation: Our lysates are made using RIPA buffer to which we add a protease inhibitor cocktail and phosphatase inhibitor cocktail (ratio: 300:100:10). This means that the protein of interest is denatured. If you require a native form of the protein please use the live cell version. Please refer to our lysis protocol for further details on how our lysates are prepared.

User storage instructions: Lyophilizate may be stored at 4°C. After reconstitution, store at -20°C for short-term storage or -80°C for long-term storage.

This product is subject to limited use licenses from The Broad Institute and ERS Genomics Limited, and is developed with patented technology. For full details of the limited use licenses and relevant patents please refer to our limited use license and patent pages.

What's included?

{ "values": { "1Kit": { "sellingSize": "1 Kit", "publicAssetCode":"ab263206-1Kit", "assetComponentDetails": [ { "size":"1 x 100 µg", "name":"Human FUK knockout HEK293T cell lysate", "number":"AB263206-CMP01", "productcode":"" }, { "size":"1 x 100 µg", "name":"Human wild-type HEK293T cell lysate", "number":"AB263206-CMP02", "productcode":"" } ] } } }

Properties and storage information

Gene name
FCSK
Gene editing type
Knockout
Gene editing method
CRISPR technology
Knockout validation
Sanger Sequencing
Shipped at conditions
Ambient - Can Ship with Ice
Appropriate short-term storage conditions
-20°C
Appropriate long-term storage conditions
-20°C

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

The protein FUK also known as fucokinase functions mechanistically as an enzyme that catalyzes the phosphorylation of L-fucose a monosaccharide involved in various metabolic processes. The molecular mass of FUK is approximately 131 kDa. FUK is primarily expressed in the liver but also in other tissues like the kidney and brain where it performs its enzymatic role as part of cellular metabolism.
Biological function summary

FUK plays a role in the salvage pathway of L-fucose metabolism. This pathway recycles free L-fucose into GDP-fucose which becomes essential for glycoprotein and glycolipid synthesis. FUK operates not as part of a larger protein complex but individually facilitating the utilization of fucose derived from dietary sources or breakdown of glycoproteins. The enzyme regulates intracellular concentrations of fucose impacting cell surface glycoconjugates important for cell signaling.

Pathways

FUK integrates into the fucose salvage pathway that links to glycosylation processes. This situates FUK within the larger context of glycan biosynthesis pathways where it intersects with enzymes such as GDP-fucose synthase. These pathways significantly influence the modification and function of proteins and lipids on cell surfaces affecting cellular communication and host-pathogen interactions.

FUK has connections to congenital disorders of glycosylation and cancer. Deficiencies in FUK enzyme activity can lead to disrupted fucosylation which contributes to clinical features seen in glycosylation disorders. In cancer abnormal fucose metabolism affects tumor progression and metastasis involving interactions with proteins such as fucosyltransferases which modify glycans on cell surfaces. Understanding FUK's role could provide insights into therapeutic approaches for glycol-related diseases.

Quality control

STR analysis

CSF1PO, D13S317, D7S820, D5S818, TH01, D16S539, TPOX

Cell culture

Biosafety level

EU: 2 US: 2

Adherent/suspension

Adherent

Gender

Female

Product protocols

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com